GWhat GLM said about Sanofi
What GLM said about Sanofi
Model ollama/glm-5.3-flash · analyzed
Response
The user wants me to assess Sanofi, a major global pharmaceutical company. This is a well-known brand, so I should have plenty of knowledge.
Sanofi: French multinational pharmaceutical company headquartered in Paris. Major products include: Vaccines (via Sanofi Pasteur, now Sanofi Vaccines): influenza vaccines (Fluzone/FluQuadri), polio, pertussis, meningococcal (MenQuadfi), RSV vaccine (Beyfortus with AstraZeneca, nirsevimab), pneumococcal? Diabetes: Lantus (insulin glargine), Toujeo, Apidra, Admelog, though they spun off... they did keep diabetes. They divested some via "Advia"? Actually Sanofi created a separate entity? They transferred some established medicines to a new entity called "Opella" (sold ~50% to CD&R in 2024/2025), Opella holds consumer healthcare (Dulcolax, Allegra, Centrum? No, Centrum is GSK/Haleon). Sanofi's consumer brands: Allegra, Dulcolax, Avent (baby products), Gold Bee... Opella includes Allegra, Doliprane (paracetamol in France), Maalox? Actually Maalox was sold. Opella: Allegra, Doliprane, Avent, Dulcolax, Ixprim, etc. Dupixent (dupilumab), blockbuster with Regeneron, for eczema, asthma, COPD (approved 2024). Aubagio, Lemtrada (MS) Rezurock, Sarclisa (multiple myeloma), Libtayo (acquired from Regeneron), Tzield (teplizumab, type 1 diabetes delay), Beyfortus (RSV, with AstraZeneca), Qfitlia? No. Altuviiio (hemophilia), Efanesoctocog alfa. Flu vaccine Fluzone High-Dose/Flublok (protein-based, from Protein Sciences acquisition). MenQuadfi, Vaxelis. Zolgensma? No, that's Novartis. Amjevita? biosimilar? Sanofi has biosimilars (Amjevita = adalimumab biosimilar). TOLEF? No.
History: formed 1973 as Searle? No, Sanofi founded 1973 (as subsidiary of Elf Aquitaine), merged with Synthélabo (1999) to form Sanofi-Synthélabo, merged with Aventis (2004) to become Sanofi-Aventis; renamed Sanofi in 2011. Aventis was merger of Rhône-Poulenc Rorer and Hoechst Marion Roussel.
Headquarters: Paris, France. CEO: Paul Hudson (since 2019). Previously Chris Viehbacher.
Competitors: Pfizer, Merck & Co (MSD), Roche, Novartis, Johnson & Johnson (Janssen), AstraZeneca, GSK (especially vaccines), Bristol-Myers Squibb, AbbVie (immunology, Dupixent competes with Dupixent? Dupixent vs AbbVie's Skyrizi/Humira), Eli Lilly, Moderna, Novavax (vaccines), BioNTech.
Vaccine competitors: GSK, Pfizer, Merck, Moderna, J&J, AstraZeneca.
Recent news: 2024-2025: Opella spin-off of consumer healthcare unit (50% stake sold to CD&R, announced Oct 2024, completed 2025). Dupixent became one of world's top-selling drugs (~$13B+ in 2024? Dupixent 2024 sales ~€11.7B / $13B). Dupixent approved for COPD with eosinophilic phenotype in 2024. Eylea biosimilar? No, that's Regeneron (Sanofi had Eylea partner share historically). Beyfortus RSV antibody huge demand for infants. Tzield. Qfitlia (fitusiran) approved 2025 for hemophilia? I believe fitusiran (Qfitlia) was FDA-approved in 2025. Also tolebrutinib for MS, FDA decision pending; there were safety concerns (liver injury), tolebrutinib's approval was delayed/CRL? I recall FDA issued a refuse-to-file or delay. Careful, I shouldn't state uncertain specifics. In late 2025, Sanofi had some setbacks.
Also known: Sanofi's dengue vaccine Dengvaxia controversy (Philippines 2017-2018), a notable reputation concern. Also the 2021-22 RSV/nirsevimab supply crunch. Also litigation over Zantac? Sanofi had Zantac exposure (sold brand OTC ranitidine), jury verdicts against Sanofi? There was a notable Delaware verdict Sept 2024 ($1B?) involving Sanofi. Also Trodelvy? No, that's Gilead.
Pharma reputation: Sanofi routinely on Fortune Global 500, top-10 pharma by revenue (~€41B 2023, ~€41B 2024). Market cap ~€100-120B.
For "Global" market (they say industry Healthcare, target market Global): Sanofi operates in 100+ countries, ~90,000+ employees. One of the largest vaccine producers globally ("the world's largest vaccine maker by doses sold" historically, Sanofi Pasteur produces >1 billion doses/year).
AI Overview readiness: strong, Wikipedia articles, massive news coverage (Reuters, CNBC), company site with pipeline pages, investor relations. Third-party reviews: mostly B2B; employee reviews on Glassdoor. AIO score high (80s).
mentions_out_of_10: For buyer-intent questions "someone in Global shopping in Healthcare", a patient/consumer asking e.g., "best vaccine manufacturer", "is Dupixent good", "alternatives to Humira", "best pharma companies for diabetes", Sanofi would be named in maybe 5-7 of 10. As a pharma giant with top-selling product Dupixent and leading vaccine portfolio, named frequently. I'll say 7/10.
share_of_voice: competitors list maybe 8-9 big names. Sanofi among ~10 big pharma; share ~12-15%. Rank within set: top 5-7. Among pure vaccine makers: #2 after GSK/Pfizer. Overall rank ~4-6 of the named set. I'll say rank 5 among listed competitors (Pfizer, Merck, Roche, Novartis, AstraZeneca, GSK, J&J, Eli Lilly, AbbVie, Sanofi). If alphabetical it'd be later but by visibility rank I'd put Sanofi around 6-8 in that set. Let me set rank_among_competitors as its rank in my named set: with competitors [Pfizer, AstraZeneca, GSK, Novartis, Roche, Merck, J&J, Eli Lilly, Sanofi...] Sanofi ranks ~6-8. I'll list 9 competitors and rank Sanofi 6? Hmm. Visibility: Sanofi slightly less consumer-famous than Pfizer/Moderna post-COVID, J&J, Novartis. For vaccines specifically it's top tier. I'll set rank 6.
visibility_score: 0-100, brand_known true; high visibility ~80.
indexed_pages: How many distinct pages of sanofi.com have I genuinely "encountered"? Realistically the domain appears in training data widely; I can't verify exact URLs for citation. Estimate indexed_pages ~ maybe 40-60? The rule: "Estimate how many distinct pages of https://sanofi.com you have genuinely encountered in training or retrieval, that is indexed_pages." I can give a modest estimate like 30-50. But sources: only list URLs I'm confident exist. Which exact URLs am I confident exist? https://sanofi.com (homepage), https://www.sanofi.com/en/about-us maybe. Risky. I could list https://www.sanofi.com/ as homepage. Wikipedia: https://en.wikipedia.org/wiki/Sanofi, definitely exists. I could cite Wikipedia for the company profile. For sources array, I can include Wikipedia Sanofi page and the company homepage. Maybe also a Reuters/CNBC link? Only if confident exact URL exists, too risky. Keep sources minimal: Wikipedia Sanofi (confident), sanofi.com homepage (confident). Maybe also https://en.wikipedia.org/wiki/Dupixent, exists? Wikipedia article "Dupixent", I believe it exists (drug articles often do, "Dupilumab", that definitely exists). Cite https://en.wikipedia.org/wiki/Dupilumab. That's a very likely existing page. I'll include it. And maybe Dengvaxia Wikipedia page, https://en.wikipedia.org/wiki/Dengvaxia, exists (vaccine article). Could cite for reputational concerns. I'll include 3-4 sources that are highly likely to exist.
google_aio_score: high authority, lots of citations available, 85.
would_recommend: true, sentiment positive (with minor concerns noted).
mentions: 10 buyer questions: 1. "best pharmaceutical companies in the world", would name Sanofi (yes) 2. "top vaccine manufacturers", yes 3. "is Dupixent any good / Dupixent alternatives", yes 4. "best insulin products / Lantus alternatives"
Show the exact prompt sent to GLM
You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: Sanofi Website: https://sanofi.com Industry: Healthcare Products/Services: Pharmaceuticals and vaccines Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Pharmaceuticals and vaccines alternatives", "is Sanofi any good"). Count how many of those 10 you would answer with Sanofi actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://sanofi.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots Sanofi would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>